Chinese
Cladribine tablets for relapsing–remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study
Overview of attention for article published in Multiple Sclerosis and Related Disorders, September 2011
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (60th percentile)
Readers on
- mendeley
- 57 Mendeley